7-enzymes C Flashcards
what kind of curve is the michaelis-menten kinetics curve
logarithmic
do allosteric enzymes follow the michaelis-menten kinetics curve
no
what kind of curve does allosteric enzymes folloe
sigmoidal curves
what kind of allostery is cooperative substrate binding
positive allostery
what are the two states called in the allostery cooperative stuff
R and T states
what does the T state mean
tense and low affinity for substrate
what does the R state mean
relaxed state and high affinity for substrate
do effects bind covalently or non-covalently to regulatory sites
non-covalently
what is homoallostery
the substrates act as effects (like oxygen on hemoglobin)
where to homoallosteric effectors bind
to active sites or regulatory sites
what is heteroallostery
when the substrates are not the effectors (like BPG on hemoglobin)
where to heteroallosteric enzymes bind
to regulatory sites
what kind of structure do many allosteric enzymes have
quaternary
where can regulatory sites be (2 options we learned)
their own subunit but they may be on catalytic subunits
what can effects do to activity
increase (positive) or decrease (negative)
what do positive effectors do to the graph
shift to the left
which state do positive effects favor
the R state
what is Km
concentration of substrate it takes to get to 50% of Vmax
what do negative effectors do to the graph
shift it to the right
which state do negative effects favor
the T state
what is a generalization of the symmetry model of allostery
that the enzyeme can either be only in R or T state, no inbetween
what kind of structures do allosteric proteins in symmetry model of allostery have
quaternary structure
what are the states that each oligomer can exist in in symmetry model of allostery
in R or T state
what causes a shift in equilibrium in T and R states in symmetry model of allostery
when ligands/substrates bind (with different addinities)
what state is the enzyme in when there is no substrate bound (in symmetry model of allostery)
almost exclusively T state
which state in symmetry model of allostery is high activity
R state
which state in symmetry model of allostery is low activity
T state
what is the sequential model of allostery
when binding of substrate causes a conformational change which makes other subunits switch to the R state
what is in the symmetry model of allostery
binding of substrate affects the probability that the enzyme is in R or T state (the entire enzyme as a whole)
what kind of structure do the enzymes in sequention model of allostery have
quaternary structure
what are the states that each subunit can exist in in symmetry model of allostery
T or R state
is it the subunit or oligomer that can be in either T or R state in sequential model of allostery
subunits
is it the subunit or oligomer that can be in either T or R state in symmetry model of allostery
oligomer (whole enzyme, not just subunits)
is symmetry maintained in the sequential model of allostery
why
no, the subunits are not necessarily in the same conformation
what happens once a ligand binds in the sequential model of allostery
1 subunit becomes R state, there is an increased affinity for substrate in the other subunits
what is ATCase (what does it stand for)
aspartate transcarboamoylase
what kind of structure does ATCase (aspartate transcarboamoylase) have
quaternary
how many catalytic subunits does ATCase (aspartate transcarboamoylase)
6
how many regulatory subunits does ATCase (aspartate transcarboamoylase)
6
what is the symmetry for ATCase (aspartate transcarboamoylase)
D3
what is the role of ATCase (aspartate transcarboamoylase)
first step in CTP synthesis
what activates ATCase (aspartate transcarboamoylase)
ATP
which model of allostery does ATCase (aspartate transcarboamoylase) follow
symmetry
what inhibits ATCase (aspartate transcarboamoylase)
and how (which mechanism)
CTP, feedback inhibited
what composes the protomers in ATCase (aspartate transcarboamoylase)
1 catalytic and 1 regulatory subunit
how many protomers in ATCase (aspartate transcarboamoylase)
6
what is feedback inhibition
when the concentration of the end product of a pathway often signals the amount of activity required in the pathway